MONALDI, CECILIA
 Distribuzione geografica
Continente #
NA - Nord America 566
EU - Europa 384
AS - Asia 203
AF - Africa 55
SA - Sud America 3
Totale 1.211
Nazione #
US - Stati Uniti d'America 562
IT - Italia 145
SG - Singapore 107
SE - Svezia 58
GB - Regno Unito 55
CN - Cina 52
DE - Germania 44
IE - Irlanda 38
TG - Togo 34
IN - India 24
NG - Nigeria 12
JO - Giordania 9
FR - Francia 8
RU - Federazione Russa 7
CH - Svizzera 5
CI - Costa d'Avorio 5
BG - Bulgaria 4
CA - Canada 4
FI - Finlandia 4
PL - Polonia 4
ZA - Sudafrica 4
EE - Estonia 3
ID - Indonesia 3
UA - Ucraina 3
BY - Bielorussia 2
DK - Danimarca 2
EC - Ecuador 2
IQ - Iraq 2
TR - Turchia 2
CL - Cile 1
HK - Hong Kong 1
IR - Iran 1
KR - Corea 1
NL - Olanda 1
NO - Norvegia 1
SA - Arabia Saudita 1
Totale 1.211
Città #
Chandler 114
Singapore 98
Southend 50
Bologna 38
Dublin 38
Lomé 34
Fairfield 33
Princeton 24
Redmond 20
Santa Clara 20
Boardman 19
Wilmington 19
Ashburn 17
Woodbridge 14
Houston 13
Abeokuta 12
Berlin 11
Seattle 11
Cambridge 10
Amman 9
Turin 9
Milan 8
Rome 7
Florence 6
New York 6
San Diego 6
Abidjan 5
Ann Arbor 5
Beijing 5
Bern 5
Boydton 5
Zhengzhou 5
Dehradun 4
Des Moines 4
Sofia 4
Warsaw 4
Westminster 4
Bremen 3
Brescia 3
Castel Madama 3
Catania 3
Helsinki 3
Jakarta 3
Medford 3
Modena 3
Mountain View 3
Nanjing 3
Padova 3
Saint Petersburg 3
Shanghai 3
Shenyang 3
Tianjin 3
Toronto 3
Albignasego 2
Ankara 2
Avellino 2
Bochum 2
Cervia 2
Changsha 2
Fano 2
Francofonte 2
Frederiksberg 2
Grand Forks 2
Guangzhou 2
Guayaquil 2
Imola 2
Latina 2
Malvern 2
Minsk 2
Miradolo Terme 2
Mumbai 2
Munich 2
Norwalk 2
Noventa Vicentina 2
Olalla 2
Parma 2
Siena 2
Trecate 2
Venice 2
Bangalore 1
Baoding 1
Bühl 1
Canzo 1
Casalecchio di Reno 1
Cedar Knolls 1
Cesena 1
Changzhou 1
Chengdu 1
Dearborn 1
Foshan 1
Frankfurt am Main 1
Fremont 1
Gaomi 1
Harbin 1
Hebei 1
Jiaxing 1
Jinan 1
Jinhua 1
Kilburn 1
Lanzhou 1
Totale 817
Nome #
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia 146
FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage 117
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors 115
Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis 102
Polo-like Kinase-1 and Aurora Kinase A As Novel Therapeutic Targets in Neoplastic Mast Cells 92
SETD2 Non-Genomic Loss of Function and p53 Functional Inactivation in Advanced Systemic Mastocytosis (SM): Pathogenetic and Therapeutic Implications 82
The role of hypoxic bone marrow microenvironment in acute myeloid leukemia and future therapeutic opportunities 80
Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells 79
Recent advances in the molecular biology of systemic mastocytosis: Implications for diagnosis, prognosis, and therapy 74
Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia 57
Systemic mastocytosis: Molecular landscape and implications for treatment 56
Targeting leukemic stem cells in chronic myeloid leukemia: Is it worth the effort? 52
Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia 49
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors 35
CML-184 A Novel Droplet Digital PCR Strategy for Rapid and Sensitive Detection of BCR::ABL1 Kinase Domain Mutations Conferring Resistance to Second-Generation Tyrosine Kinase Inhibitors 34
MPN-182 Droplet Digital PCR for Non-Invasive Detection of the KIT D816V Mutation in the Peripheral Blood of Patients With Suspected Systemic Mastocytosis 32
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted 25
Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights 23
Unstable major molecular response as a trigger for next generation sequencing-based BCR::ABL1 mutation testing in chronic myeloid leukemia 9
Totale 1.259
Categoria #
all - tutte 4.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.506


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202068 0 0 0 0 11 6 16 8 9 6 4 8
2020/202182 9 4 0 0 1 2 9 23 10 3 8 13
2021/2022200 4 2 6 4 22 13 2 21 14 15 57 40
2022/2023426 44 73 17 34 44 24 24 17 78 15 44 12
2023/2024144 2 27 14 22 13 13 7 19 3 10 11 3
2024/2025286 24 122 63 51 26 0 0 0 0 0 0 0
Totale 1.259